Crossmark

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns

Crossref DOI link: https://doi.org/10.1016/j.eimce.2022.04.014

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez Fabra, David

Herrero Jordán, Tina
License Information

Text and Data Mining valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2022.04.014

Content Type: simple-article

Copyright: © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.